Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of TSHA will decline by -12.74% over the next 2 Weeks and hit $5.13 by Thursday, August 13, 2026. In that time frame, TSHA's share price is expected to range between $4.81 and $5.47.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Aug 13, 2026 | 4.81 | 5.13 | 5.47 |
| Aug 12, 2026 | 4.87 | 5.18 | 5.51 |
| Aug 11, 2026 | 4.86 | 5.18 | 5.47 |
| Aug 10, 2026 | 4.80 | 5.10 | 5.40 |
| Aug 7, 2026 | 4.98 | 5.27 | 5.55 |
| Aug 6, 2026 | 5.13 | 5.42 | 5.72 |
| Aug 5, 2026 | 5.20 | 5.48 | 5.76 |
| Aug 4, 2026 | 5.20 | 5.47 | 5.79 |
| Aug 3, 2026 | 5.13 | 5.40 | 5.70 |
| Jul 31, 2026 | 5.27 | 5.56 | 5.84 |
TSHA shares fell -0.26% in Friday, July 31, 2026's trading session, dropping from a previous close of $5.88 to move at $5.86. The stock demonstrated notable intraday movement (see TSHA's key stats for a full breakdown), fluctuating between $5.73 and $5.92, a +3.41% trading range. While recent weeks have seen some volatility, TSHA has managed to secure a +5.02% gain over the past 2 weeks. The downward price movement was accompanied by decreased trading volume, with approximately 2.29M shares changing hands, 1.1M fewer than the previous session. This amounted to $13.41M in total market activity.
Will TSHA Continue Its Downward Trend?
According to analyst ratings and projections for TSHA, Taysha Gene Therapies, Inc. shares are anticipated to decrease by -7.06%, potentially reaching $5.47 per share by August 13, 2026. Short-term technical indicators currently suggest a neutral sentiment for TSHA. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 16 positive trading days within the past 30 sessions. Based on the TSHA stock forecast, now is not the best time to buy TSHA stock because its current trading price is +14.31% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on TSHA covering social and institutional perspectives.
TSHA Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into TSHA's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 49.06% to 51.11%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 50.82%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 52.03%, maintains a neutral outlook for the long term. Insights into TSHA's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Taysha Gene Therapies Short-Term Forecasts
TSHA Forecast For Next 5 Days
Our algorithm anticipates Taysha Gene Therapies (TSHA) stock could hit $5.17 by Aug 07, 2026. This represents a -11.75% fall from today's price, following a -4.53% change over the past five days.
TSHA Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Taysha Gene Therapies, Inc. (TSHA) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $5.02, which would mean a -14.33% decrease from the current price of $5.86. Projections for this period range from a high of $6.13 to a low of $4.02.
TSHA Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Taysha Gene Therapies's price over the next three months point to a rise. TSHA stock is expected to peak at $34.40 on Oct 08, 2026 after potentially dipping to $22.00 on Jul 31, 2026. On average, TSHA is likely to trade around $29.95 in the coming 90 days.
Taysha Gene Therapies Stock Forecast 2025
Based on our predictive models, Taysha Gene Therapies (TSHA) is expected to trade between $22.00 and $34.40 throughout 2026. This would result in an average price of $29.55, potentially offering investors a +404.27% return from current levels.
Taysha Gene Therapies, Inc. Monthly Forecast 2026–2027
July 2026
According to our latest forecast models, Taysha Gene Therapies, Inc. (TSHA) is positioned to show a strong performance in July 2026. The price is predicted to move between $22.00 and $22.29, settling at an average of $22.16. This could translate to a +278.16% gain.
August 2026
Based on current market signals, Taysha Gene Therapies, Inc. is projected to trend august 2026. We forecast a trading range from $23.06 to $29.62, with a likely average price of $26.85. Investors could expect a potential return of +358.19%.
September 2026
Our predictive algorithms indicate Taysha Gene Therapies, Inc. stock may see a shift in September 2026. The expected range spans $29.40–$33.35, with an average target of $31.47. This represents a positive outlook and a possible gain of +437.03%.
October 2026
Analyzing established trends, Taysha Gene Therapies, Inc. looks set to move in October 2026. Projections place the stock between $27.29 and $34.40, averaging around $31.75. This suggests a +441.81% gain from current levels.
November 2026
Market indicators suggest Taysha Gene Therapies, Inc. could experience notable changes during November 2026. Prices could fluctuate within $22.29 to $30.61, with a midpoint forecast of $25.24. The stock might deliver a +330.72% gain.
December 2026
Forecasting for December 2026, models estimate that Taysha Gene Therapies, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $30.62 and $34.25, averaging $32.33. This signals a positive trajectory with potential returns around +451.71%.
January 2027
According to our latest forecast models, Taysha Gene Therapies, Inc. (TSHA) is positioned to show a strong performance in January 2027. The price is predicted to move between $21.69 and $33.99, settling at an average of $27.97. This could translate to a +377.30% gain.
February 2027
Based on current market signals, Taysha Gene Therapies, Inc. is projected to trend february 2027. We forecast a trading range from $21.50 to $27.15, with a likely average price of $24.49. Investors could expect a potential return of +317.92%.
March 2027
Our predictive algorithms indicate Taysha Gene Therapies, Inc. stock may see a shift in March 2027. The expected range spans $15.69–$24.93, with an average target of $19.57. This represents a positive outlook and a possible gain of +233.96%.
April 2027
Analyzing established trends, Taysha Gene Therapies, Inc. looks set to move in April 2027. Projections place the stock between $15.05 and $27.33, averaging around $20.40. This suggests a +248.12% gain from current levels.
May 2027
Market indicators suggest Taysha Gene Therapies, Inc. could experience notable changes during May 2027. Prices could fluctuate within $25.84 to $29.20, with a midpoint forecast of $26.46. The stock might deliver a +351.54% gain.
June 2027
Forecasting for June 2027, models estimate that Taysha Gene Therapies, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $25.25 and $30.24, averaging $27.89. This signals a positive trajectory with potential returns around +375.94%.
July 2027
According to our latest forecast models, Taysha Gene Therapies, Inc. (TSHA) is positioned to show a strong performance in July 2027. The price is predicted to move between $24.69 and $28.55, settling at an average of $25.78. This could translate to a +339.93% gain.
TSHA's history of dividends and stock splits also plays a role in long-term investor confidence.